University Clinical Research is categorized under Research Institute in Deland, FL and active since 1998.
University Clinical Research was established in 1998, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Ben Trevathan, Owner at the company’s single location by writing to 860 Peachwood Drive, Deland, Florida FL 32720 or by phoning (386) 740-0770. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | University Clinical Research |
Contact Person: | Ben Trevathan, Owner |
Address: | 860 Peachwood Drive, Deland, Florida 32720 |
Phone Number: | (386) 740-0770 |
Website Address: | availclinical.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research Institute |
SIC Code: | 8733 |
NAICS Code: | 6214930 |
Share This Business: |
University Clinical Research was started in 1998 to provide professional Research Institute under the SIC code 8733 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Ben Trevathan, Owner for inquiries that concern University Clinical Research by calling the company number (386) 740-0770, as your correspondence is most welcome. Additionally, the physical location of the single location of University Clinical Research can be found at the coordinates 29.04504,-81.31506 as well as the street address 860 Peachwood Drive in Deland, Florida 32720.
For its online presence, you may visit University Clinical Research’s website at availclinical.com and engage with its social media outlets through on Twitter and on Facebook.